Intervention

Laboratory Testing

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions5

Lead sponsors shown2

Clinical trials

3 shown

Cardiac Outcomes With Near-Complete Estrogen DeprivationNCT05309655 · 2022-09-02

ACTIVE_NOT_RECRUITING

Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1NCT00968656 · 2009-01-01

COMPLETED

Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)NCT00968409 · 2007-01-01

COMPLETED

Common conditions

Breast Cancer3 Cardiovascular Complications1 Diffuse Large B-cell Lymphoma1 Head and Neck Cancer1 Triple Negative Breast Cancer1

Leading sponsors

Washington University School of Medicine 2 Duke University 1

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE12

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.